ConductScience.org, home

Trial · NCT07488715

High-Intensity Interval Training Across Exercise Environments: Acute Effects on Physiological Stress, Cardiovascular Responses, Executive Function, and Psychological Experience

NCT07488715, Not applicable, Completed, Shanghai University of Sport

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. High-Intensity Interval Training Across Exercise Environments: Acute Effects on Physiological Stress, Cardiovascular Responses, Executive Function, and Psychological Experience. Trials, record NCT07488715. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07488715

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
High-Intensity Interval Training Across Exercise Environments: Acute Effects on Physiological Stress, Cardiovascular Responses, Executive Function, and Psychological Experience
NCT number
NCT07488715
Status
Completed
Phases
Not applicable
Enrollment
28 participants, actual
Lead sponsor
Shanghai University of Sport
Conditions
Sport Participation
Interventions
HIIT in Indoor Environment, HIIT in Outdoor Athletic Track, HIIT in Green Park Environment
First posted
2026-03-23
Last updated
2026-07-21

Source ClinicalTrials.gov

Registered outcomes11

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange in Salivary Cortisol ConcentrationAdministered at baseline (pre-exercise) and post-exercise.
SecondaryChange in Inhibitory Control Assessed by the Stroop TaskAdministered at baseline (pre-exercise) and post-exercise.
SecondaryChange in Cognitive Flexibility Assessed by the More-odd-shifting TaskBaseline (pre-exercise) and 20 minutes post-exercise
SecondaryChange in Heart Rate Variability (HRV)20 minutes pre-exercise, immediately post-exercise, 5 minutes post-exercise, 10 minutes post-exercise, and 20 minutes post-exercise
SecondaryChange in Blood Pressure20 minutes pre-exercise, immediately post-exercise, 5 minutes post-exercise, 10 minutes post-exercise, and 20 minutes post-exercise
SecondaryChange in Heart Rate20 minutes pre-exercise, immediately post-exercise, 5 minutes post-exercise, 10 minutes post-exercise, and 20 minutes post-exercise
SecondaryMood State Assessed by Positive and Negative Affect Schedule (PANAS)Administered at baseline (pre-exercise) and post-exercise.
The Positive and Negative Affect Schedule (PANAS) consists of two subscales to measure both positive affect (10 items) and negative affect (10 items) reflecting the past week. Items are rated on a 5-point scale (1=very slightly or not at all, 5=extremely). The total score for the Positive Affect scale ranges from 10 to 50, with higher scores indicating higher levels of positive emotions (a better outcome). The total score for the Negative Affect scale ranges from 10 to 50, with higher scores indicating higher levels of negative emotions (a worse outcome).
SecondaryChange in Exercise Enjoyment Assessed by Physical Activity Enjoyment Scale (PACES)Baseline (pre-exercise) and 20 minutes post-exercise
The Physical Activity Enjoyment Scale (PACES) is used to evaluate the participant's subjective enjoyment of the exercise session. The scale consists of 18 items, each rated on a 7-point scale (1=completely disagree, 7=completely agree). The total score ranges from 18 to 126. Higher scores indicate a greater level of exercise enjoyment (a better outcome).
SecondaryHabitual Sport Motivation Assessed by Sport Motivation Scale (SMS)Administered at baseline (pre-exercise) and post-exercise.
The Sport Motivation Scale (SMS) is used to evaluate habitual, long-term motivation toward sports (reflecting on the past year). It consists of 28 items rated on a 7-point scale (1=does not correspond at all, 7=corresponds exactly). The total global score ranges from 28 to 196. Higher scores indicate higher levels of self-determined motivation toward sports (a better outcome).
SecondaryAttentional Control Assessed by Attentional Control Scale (ACS)Administered at baseline (pre-exercise) and post-exercise.
The Attentional Control Scale (ACS) is used to assess the participant's general trait ability to control attention and focus. The scale consists of 20 items rated on a 4-point scale (1=almost never, 4=always). The total score ranges from 20 to 80. Higher scores indicate better attentional control capabilities (a better outcome).

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests1

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed as
Stroop Color-Word TestSecondary outcome

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07488715

GET https://conductscience.org/api/trials/v1/NCT07488715/registered